Buscar resultados de ensayos clínicos
Mantle Cell Lymphoma - 35 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Study of Mantle Cell Lymphoma Treatment by RiBVD Condición: Mantle Cell Lymphoma Fecha: 2011-10-20 Intervenciones: Drug: RiBVD Every cycle: |
Completed |
Nombre del estudio: Intensive Induction Therapy Followed by High Dose Chemo and BM Transplant for Mantle Cell Lymphoma Condición: Mantle Cell Lymphoma Fecha: 2007-12-21 Intervenciones: Procedure: Intensive Induction-BMT Patients will undergo an induction regimen consisting of 1 cycle of c |
Not yet recruiting |
Nombre del estudio: The Efficacy and Safety of Bortezomib Combined With Fludarabine and Cytarabine Treatment for Mantle Cell Lymphoma Condición: Mantle Cell Lymphoma Fecha: 2016-10-11 Intervenciones:
|
Recruiting |
Nombre del estudio: Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma Condición: Mantle-Cell Lymphoma Fecha: 2009-04-07 Intervenciones:
|
Completed |
Nombre del estudio: Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma Condición: Mantle Cell Lymphoma Fecha: 2005-07-07 Intervenciones:
|
Completed |
Nombre del estudio: Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma Condición: Mantle Cell Lymphoma Fecha: 2008-03-04 Intervenciones:
|
Completed |
Nombre del estudio: Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02) Condición: Mantle Cell Lymphoma Fecha: 2007-07-20 Intervenciones: Drug: Y-90 Ibritumomab tiuxetan Study Design |
Completed |
Nombre del estudio: A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy Condición: Mantle Cell Lymphoma Fecha: 2012-05-14 Intervenciones: Drug: Ibrutinib Type=exact number, unit=mg, number=560, form=capsule, route=oral use. 560 mg oral ibruti |
Active, not recruiting |
Nombre del estudio: Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma. Condición: Mantle Cell Lymphoma Fecha: 2009-08-20 Intervenciones:
|
Completed |
Nombre del estudio: Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy Condición: Mantle Cell Lymphoma Fecha: 2012-07-18 Intervenciones:
|